Free Delivery Over $100
|
|
|||
|
||||
OverviewThe production of recombinant biopharmaceuticals with antiviral and antiproliferative properties is one of the major aims of advanced genetic engineering. Interferon alpha 2b belongs to the class of recombinant therapeutics which is equally effective against viral infections and carcinomas. Recombinant human IFN I 2b is widely used FDA approved protein drug with global sale level is expected to reach up to 5.8 billion US dollars by 2010 due to its increased demand as a result of high prevalence of hepatitis infections and carcinomas in developed as well as developing countries including Pakistan. In the current research a process was developed for the production of this recombinant interferon alpha 2b drug by adopting advanced molecular and biochemical strategies. Intragene modifications at specific amino acids were also made to produce antiviral gene sequences with improved antiviral properties. Human interferon alpha 2b gene analysis was also established in blood cancers (AML and ALL) in order to find out mutations of clinical significance in theses cancers. Full Product DetailsAuthor: Nasir Mahmood , M. Akhtar FRS , Naeem RashidPublisher: VDM Verlag Dr. Muller Aktiengesellschaft & Co. KG Imprint: VDM Verlag Dr. Muller Aktiengesellschaft & Co. KG Dimensions: Width: 22.90cm , Height: 1.00cm , Length: 15.20cm Weight: 0.267kg ISBN: 9783639273526ISBN 10: 3639273524 Pages: 176 Publication Date: 03 April 2011 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
